Hologic Completes Acquisition, Appoints New CEO
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 07 2026
0mins
Source: Newsfilter
- Acquisition Completed: Hologic, Inc. has completed its acquisition by funds managed by Blackstone and TPG, valued at up to $79 per share, marking its transition to a private company and expected to enhance its innovation capabilities in women's health.
- CEO Appointment: Joe Almeida has been appointed as CEO, effective immediately, bringing extensive experience in medical technology that will provide new strategic direction and strengthen Hologic's leadership in global women's health.
- Shareholder Returns: Hologic shareholders will receive $76 per share in cash plus a non-tradable contingent value right (CVR) worth up to $3, with total returns potentially reaching $79 per share, designed to incentivize the company to achieve revenue targets over the next two years.
- Market Impact: This acquisition and the establishment of a new leadership team are expected to drive further development in medical technology for Hologic, enhancing its market competitiveness while attracting more investment to support innovation and business expansion.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
